Relay Therapeutics RLAY
NASDAQ RLAY
$18.55 +0.50 (+2.74%)
As of: Oct 1, 2026 · 3:49 PM EDT

Relay Therapeutics (RLAY) Preferred Dividend Payments (2020)

Updated

Relay Therapeutics (RLAY) posted Preferred Dividend Payments of $177.79 million for Q3 2020.

Analysis

Relay Therapeutics (RLAY) Preferred Dividend Payments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Relay Therapeutics 3.94 Bn 3.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 177.79 Mn
API Access

Relay Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=RLAY&period=max&api_key=YOUR_API_KEY